The US regulator’s go-ahead is a boon for people with a rare form of porphyria that results in painful photosensitivity.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ratner, M. Patients with porphyria bask in sunlight of FDA approval. Nat Biotechnol 37, 1390–1391 (2019). https://doi.org/10.1038/s41587-019-0347-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0347-0